TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2023-02-10
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2022-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2022-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2022-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2022-03-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2022 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2021 was -$9.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2020 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $0.00 10-K · filed 2023-02-10 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $0.00 10-Q · filed 2022-07-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $0.00 derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $0.00 derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | -$9.00M 10-K · filed 2023-02-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | -$9.00M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$9.00M 10-Q · filed 2022-07-27 | ||
| 2021-03-31 | -$9.00M 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-09 |